Results 161 to 170 of about 33,909 (215)

Evolution of cefoperazone-sulbactam consumption in Romania between 2011 and 2024. [PDF]

open access: yesEur J Clin Microbiol Infect Dis
Vasile CC   +3 more
europepmc   +1 more source

Salvage Treatment of Ventilator-Associated Pneumonia Using Sulbactam-Durlobactam in a Preterm Neonate: A Case Report. [PDF]

open access: yesInfect Dis Rep
Zivojinovic S   +7 more
europepmc   +1 more source

Contribution of Acinetobacter-Derived Cephalosporinase-30 to Sulbactam Resistance in Acinetobacter baumannii [PDF]

open access: yesFrontiers in Microbiology, 2015
The sulbactam resistance rate in Acinetobacter baumannii has increased worldwide. Previous reports have shown that the β-lactamase blaTEM-1 confers resistance to sulbactam in A. baumannii.
Shu-Chen Kuo   +2 more
exaly   +5 more sources

Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.

open access: yesAntimicrobial Agents and Chemotherapy, 2017
Sulbactam is one of four β-lactamase inhibitors in current clinical use to counteract drug resistance caused by degradation of β-lactam antibiotics by these bacterial enzymes. As a β-lactam itself, sulbactam is susceptible to degradation by β-lactamases.
Adam B Shapiro
exaly   +2 more sources

Synergic In-Vitro Activity of Imipenem and Sulbactam Against Acinetobacter baumannii

open access: yesClinical Microbiology and Infection, 2004
The interaction between sulbactam and imipenem was evaluated with four clinical isolates of Acinetobacter baumannii, including two isolates resistant to imipenem, one of which produced IMP-1 metallo-beta-lactamase. Two isolates (one of which was imipenem-
Ja Young Choi   +2 more
exaly   +3 more sources

The Impact of Inoculum Size on the Activity of Cefoperazone-Sulbactam Against Multidrug Resistant Organisms

open access: yesJournal of Microbiology, Immunology and Infection, 2018
Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms.
Chuang Yin-ching   +2 more
exaly   +2 more sources

Sulbactam / Ampicillin

Infection Control and Hospital Epidemiology, 1988
Sulbactam/ampicillin was recently marketed for use in several infections caused by beta-lactamase-producing organisms. Sulbactam is the second beta-lactamase inhibitor to become available in the United States. Interest in inhibition of beta-lactamases arose in the late 1960s when a combination consisting of an antibacterial agent and an enzyme ...
openaire   +1 more source

Home - About - Disclaimer - Privacy